Promising Early Results for Goflikicept in Pericarditis : vimarsana.com

The novel IL-1 inhibitor goflikicept is effective and relatively safe in idiopathic recurrent pericarditis.

Related Keywords

Russia , Petersburg , Sankt Peterburg , Valentina Myachikova , Research Laboratory Of Autoimmune , Novartis , R Pharm International , Journal Of The American College Cardiology , Research Laboratory , Autoinflammatory Diseases , American College , Biologic Therapy , Pericarditis , Pain Management , Ain Management , Nonsteroidal Anti Inflammatory Drugs Nsaids , Onsteroidal Anti Inflammatory Drugs , Saids , Rug Nonsteroidal Anti Inflammatory , Chest Pain , Angina , Ngina Pectoris , Cytokines , Pain , Chest , Tnf Alpha , Umor Necrosis Factor Alpha , Umor Necrosis Factor Tnf , Achexin , Achectin , C Reactive Protein , Corticost ,